Publication | Closed Access

Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial

Breast OncologyMedicinePharmacologyGynecologyBreast CancerPharmacotherapyMenopauseMenopause Hormone TherapyOncologyRadiation OncologyLetrozole Versus ChemotherapyEndocrine-related CancerPostmenopausal Women